Skip to main content
Genscript Biotech Corporation logo

Genscript Biotech Corporation — Investor Relations & Filings

Ticker · 1548 ISIN · KYG3825B1059 LEI · 529900YIYUOJOXSAE372 HKEX Manufacturing
Open in API
Filings indexed 819 across all filing types
Latest filing 2025-06-04 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 1548

About Genscript Biotech Corporation

http://www.genscript.com/investor-relat…

Genscript Biotech Corporation is a world-leading technology and service provider specializing in life science research and manufacturing. The company offers a comprehensive portfolio of services and products essential for fundamental life science research, translational biomedical research, and early drug discovery and development. Core offerings include custom synthesis of genes, peptides, proteins, and antibodies, alongside molecular cloning and oligonucleotide production. GenScript also provides Contract Development and Manufacturing Organization (CDMO) solutions for innovative therapies through its specialized subsidiaries. The corporation leverages biotechnology and AI-driven approaches to advance life science solutions.

Recent filings

Filing Released Lang Actions
VOLUNTARY ANNOUNCEMENT: LEGEND BIOTECH ANNOUNCED NEW 5-YEAR SURVIVAL DATA FOR CARVYKTI IN CARTITUDE-1 STUDY FOR MULTIPLE MYELOMA AT 2025 ASCO ANNUAL MEETING
Regulatory Filings Classification · 1% confidence The document is a voluntary announcement by GenScript Biotech Corporation on the Hong Kong Exchange regarding clinical trial survival data and references a Form 6-K filing by an associate. It does not present financial results, an AGM/EGM notice, governance details, insider dealings, dividends, capital changes, or other specific regulatory categories. It is a general corporate/regulatory announcement that does not fit any more specific filing type, so it falls under the fallback category of Regulatory Filings (RNS).
2025-06-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025
Share Issue/Capital Change Classification · 1% confidence The document is a monthly statutory return (Form FF301) submitted to HKEX detailing movements in authorised/registered share capital, issued shares, share option exercises, and other capital changes during the month. It is not an earnings release, management discussion, or simple report publication announcement, but an actual record of share issues and capital changes. This falls squarely under the category for Share Issue/Capital Change (SHA).
2025-06-04 English
Nomination Committee -Terms of Reference
Governance Information Classification · 1% confidence The document is the Terms of Reference for the Board’s Nomination Committee, detailing its constitution, membership, duties and reporting procedures. It sets out the company’s internal governance rules and board committee structure rather than financial results, transactions, or meeting announcements. This falls squarely under Governance Information, which covers internal rules and board structure.
2025-05-29 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Governance Information Classification · 1% confidence The document provides a structured listing of the company’s board composition and committee roles, detailing governance arrangements rather than announcing any specific director changes or financial data. This aligns with Governance Information (CGR).
2025-05-29 English
(1) POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 29 MAY 2025&#x3b; (2) CHANGE IN COMPOSITION OF THE BOARD&#x3b; AND (3) CHANGE IN COMPOSITION OF BOARD COMMITTEES
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an exchange announcement reporting (1) the poll results of the Annual General Meeting (AGM) held on 29 May 2025, including detailed vote counts and percentages for each resolution, and (2) subsequent changes in board composition and board committees. The primary content is the formal disclosure of shareholder voting results at the AGM, which aligns exactly with the Definition of “Declaration of Voting Results & Voting Rights Announcements” (Code: DVA). Although the announcement also includes board and committee changes, such changes are secondary to the poll results disclosure and are commonly bundled in a single announcement under Hong Kong Exchange practice. Therefore, the correct classification is DVA.
2025-05-29 English
VOLUNTARY ANNOUNCEMENT: LEGEND BIOTECH WILL PRESENT NEW DATA ON CARVYKTI FOR PATIENTS WITH MULTIPLE MYELOMA AT 2025 ASCO AND EHA ANNUAL MEETINGS
Report Publication Announcement Classification · 1% confidence The document is a short voluntary announcement (2,650 characters) stating that an associate company has filed a Form 6-K and that a related press release is available on its website. It does not present full financial results or regulatory details itself, but simply announces the publication of another report. This matches the definition of a Report Publication Announcement (RPA), which covers notices that a report is released or available online.
2025-05-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.